MedTrace Logo

Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome

NCT00138528 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2017-02-23

No results posted yet for this study

Summary

Other effects of fluvastatin are investigated in German patients with metabolic syndrome.

Conditions

  • Metabolic Syndrome

Interventions

DRUG

Fluvastatin

Sponsors & Collaborators

Principal Investigators

  • Novartis Pharmaceuticals · Novartis Pharmaceuticals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2006-02-28
Completion
2006-02-28

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00138528 on ClinicalTrials.gov